BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2010
View Archived Issues
Bruton's tyrosine kinase inhibitors reported by CGI and Genentech
Read More
Multikinase inhibitor regorafenib evaluated in NSCLC; interim phase I data presented
Read More
Maximum tolerated dose of acadesine identified in chronic lymphocytic leukemia patients
Read More
Genetic variations linked to pancreatic cancer risk
Read More
Brivaracetam dose adjustment not needed for renal dysfunction
Read More
SBR-759 superior to sevelamer HCI for hyperphosphatemia in Asian hemodialysis patients
Read More
Transition Therapeutics begins phase I study of TT-301 for CNS indications
Read More
Pfizer claims cholecystokinin-1 agonists for obesity and co-morbidities
Read More
Novel PDE5A inhibitors claimed by Chinese scientists
Read More
Janssen claims rifamycin derivatives as antibacterials
Read More
M3 receptor antagonists under study at Argenta and AstraZeneca
Read More
Myriad Pharmaceuticals changes name to Myrexis, will focus on oncology programs
Read More
Sepracor's Omnaris HFA meets primary endpoint in phase III study
Read More
Strativa receives FDA approval for Zuplenz oral soluble film
Read More
ADVENTRX reports encouraging 9-month data from stability tests of Exelbine
Read More
BioSante reports results from phase II study of its Pill-Plus oral contraceptive
Read More
FDA approves Purdue Pharma's Butrans transdermal system CIII for chronic pain
Read More
Corcept begins dosing in phase III study of Corlux in Cushing's syndrome
Read More
AstraZeneca and MRC Technology form alliance to share compound libraries
Read More
Circadin approved in the E.U. for 13-week treatment for primary insomnia
Read More
X-Chem and Roche collaborate on drug discovery
Read More
Alimera submits NDA to the FDA for Iluvien in diabetic macular edema
Read More
Cell Therapeutics files updated Pediatric Investigation Plan for pixantrone to the EMA
Read More
MorphoSys receives grant from German government for MOR-202 cancer program
Read More
Clemizole may yield high-level synergy with protease inhibitors
Read More